Please login to the form below

Not currently logged in
Email:
Password:

UDG sells stake in UniDrug

Alliance Boots will take over full control of supply chain specialist
UDG Healthcare

UDG Healthcare has sold its 50 per cent stake in healthcare supply chain specialist UniDrug to joint venture partner Alliance Boots.

The sale will allow UDG Healthcare to pay down its debts and to concentrate on other areas of its business, the company said in a statement.

UDG sold its stake for a cash consideration of $82m (€66m). The company received a net after tax profit contribution from UniDrug of €5.6m in fiscal year 2013.

UDG chief executive Liam Fitzgerald said that UniDrug had been a very successful investment for his company.

He added that its fit with UDG's core supply chain services in Northern Ireland and the Republic of Ireland was less close than before. This was due to the ongoing convergence of the pre-wholesale and wholesale markets in the UK, he explained.

“The opportunity to exit the joint venture allows UDG Healthcare to release over €80m to both reduce debt and for further investment in areas of our business which fit strategically with the future development of the group.”

Post-disposal, UDG's supply chain services division will remain an Alloga partner (pre-wholesaling) in the Republic of Ireland, and will continue to work with Alliance Boots on that basis.

The cash injection will allow UDG to follow its M&A strategy in two of the group's more profitable businesses.

Ashfield Commercial and Medical Services provides outsourced multichannel communications to healthcare professionals and patients in 22 countries. UDG created this division earlier in 2014 by bringing together a number of its agencies, later adding Galliard and Nyxeon.

Sharp Packaging Services provides pharma contract packaging and clinical trials materials services.

Article by
Tara Craig

20th August 2014

From: Marketing, Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics